• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

泛素连接酶在癌症中的作用。

Ubiquitin-Conjugating Enzymes in Cancer.

机构信息

Department of Biomedical Sciences, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

Lung Cancer Research Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea.

出版信息

Cells. 2021 Jun 4;10(6):1383. doi: 10.3390/cells10061383.

DOI:10.3390/cells10061383
PMID:34199813
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8227520/
Abstract

The ubiquitin-mediated degradation system is responsible for controlling various tumor-promoting processes, including DNA repair, cell cycle arrest, cell proliferation, apoptosis, angiogenesis, migration and invasion, metastasis, and drug resistance. The conjugation of ubiquitin to a target protein is mediated sequentially by the E1 (activating)‒E2 (conjugating)‒E3 (ligating) enzyme cascade. Thus, E2 enzymes act as the central players in the ubiquitination system, modulating various pathophysiological processes in the tumor microenvironment. In this review, we summarize the types and functions of E2s in various types of cancer and discuss the possibility of E2s as targets of anticancer therapeutic strategies.

摘要

泛素介导的降解系统负责控制各种促进肿瘤的过程,包括 DNA 修复、细胞周期阻滞、细胞增殖、细胞凋亡、血管生成、迁移和侵袭、转移和耐药性。泛素与靶蛋白的连接是由 E1(激活)-E2(连接)-E3(连接)酶级联反应依次介导的。因此,E2 酶作为泛素化系统的核心参与者,调节肿瘤微环境中的各种病理生理过程。在这篇综述中,我们总结了 E2 在各种类型癌症中的类型和功能,并讨论了 E2 作为抗癌治疗策略靶点的可能性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/8227520/32fba4551e22/cells-10-01383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/8227520/a411563cfafe/cells-10-01383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/8227520/32fba4551e22/cells-10-01383-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/8227520/a411563cfafe/cells-10-01383-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/165c/8227520/32fba4551e22/cells-10-01383-g002.jpg

相似文献

1
Ubiquitin-Conjugating Enzymes in Cancer.泛素连接酶在癌症中的作用。
Cells. 2021 Jun 4;10(6):1383. doi: 10.3390/cells10061383.
2
E2 ubiquitin-conjugating enzymes in cancer: Implications for immunotherapeutic interventions.癌症中的 E2 泛素连接酶:免疫治疗干预的意义。
Clin Chim Acta. 2019 Nov;498:126-134. doi: 10.1016/j.cca.2019.08.020. Epub 2019 Aug 21.
3
New Insights into the Role of E2s in the Pathogenesis of Diseases: Lessons Learned from UBE2O.E2s 在疾病发病机制中的作用的新见解:UBE2O 带来的启示。
Mol Cells. 2018 Mar 31;41(3):168-178. doi: 10.14348/molcells.2018.0008. Epub 2018 Mar 20.
4
Classification and interaction modes of 40 rice E2 ubiquitin-conjugating enzymes with 17 rice ARM-U-box E3 ubiquitin ligases.40 种水稻 E2 泛素连接酶与 17 种水稻 ARM-U-box E3 泛素连接酶的分类和相互作用模式。
Biochem Biophys Res Commun. 2014 Feb 21;444(4):575-80. doi: 10.1016/j.bbrc.2014.01.098. Epub 2014 Jan 29.
5
Targeting the Ubiquitin Signaling Cascade in Tumor Microenvironment for Cancer Therapy.靶向肿瘤微环境中的泛素信号级联反应用于癌症治疗。
Int J Mol Sci. 2021 Jan 14;22(2):791. doi: 10.3390/ijms22020791.
6
Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy.线粒体 E3 泛素连接酶在癌症治疗中的作用及其作为潜在治疗靶点的可能性。
Int J Mol Sci. 2023 Dec 6;24(24):17176. doi: 10.3390/ijms242417176.
7
Mechanism and disease association of E2-conjugating enzymes: lessons from UBE2T and UBE2L3.E2 共轭酶的机制与疾病关联:来自 UBE2T 和 UBE2L3 的经验教训。
Biochem J. 2016 Oct 15;473(20):3401-3419. doi: 10.1042/BCJ20160028.
8
[The role of different E3 ubiquitin ligases in regulation of the P53 tumor suppressor protein].[不同E3泛素连接酶在P53肿瘤抑制蛋白调控中的作用]
Tsitologiia. 2013;55(10):673-87.
9
Diverse roles of the E2/E3 hybrid enzyme UBE2O in the regulation of protein ubiquitination, cellular functions, and disease onset.UBE2O 作为 E2/E3 杂合酶在蛋白质泛素化、细胞功能和疾病发生中的多种作用。
FEBS J. 2019 Jun;286(11):2018-2034. doi: 10.1111/febs.14708. Epub 2018 Dec 4.
10
The importance of regulatory ubiquitination in cancer and metastasis.调节性泛素化在癌症和转移中的重要性。
Cell Cycle. 2017 Apr 3;16(7):634-648. doi: 10.1080/15384101.2017.1288326. Epub 2017 Feb 6.

引用本文的文献

1
Prognostic Value of Ubiquitination-Related Genes in Ovarian Cancer and Their Correlation With Tumor Immunity.泛素化相关基因在卵巢癌中的预后价值及其与肿瘤免疫的相关性
Hum Mutat. 2025 Jul 15;2025:8369299. doi: 10.1155/humu/8369299. eCollection 2025.
2
Uncovering the molecular targets of phytocannabinoids: mechanistic insights from inverse molecular docking fingerprint approaches.揭示植物大麻素的分子靶点:反向分子对接指纹方法的机制洞察
Front Pharmacol. 2025 Jun 27;16:1611461. doi: 10.3389/fphar.2025.1611461. eCollection 2025.
3
Predictive molecular biomarkers of radiosensitivity in adult glioma: a narrative review.

本文引用的文献

1
Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity.铂类诱导 NEDD8 连接酶 E2 UBE2F 表达保护肺癌细胞免于凋亡并导致铂类耐药。
Cell Death Dis. 2020 Nov 12;11(11):975. doi: 10.1038/s41419-020-03184-4.
2
UBE2O Promotes Progression and Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.UBE2O促进头颈部鳞状细胞癌的进展和上皮-间质转化
Onco Targets Ther. 2020 Jun 29;13:6191-6202. doi: 10.2147/OTT.S253861. eCollection 2020.
3
Targeting CDC34 E2 ubiquitin conjugating enzyme for lung cancer therapy.
成人胶质瘤放射敏感性的预测性分子生物标志物:一项叙述性综述
BMC Cancer. 2025 Jul 5;25(1):1146. doi: 10.1186/s12885-025-14514-0.
4
UBE2N inhibition abrogates cancer chemoresistance and metastasis in lung adenocarcinoma.UBE2N抑制可消除肺腺癌中的癌症化疗耐药性和转移。
Cancer Gene Ther. 2025 Jun 22. doi: 10.1038/s41417-025-00929-1.
5
Refining of cancer-specific genes in microsatellite-unstable colon and endometrial cancers using modified partial least square discriminant analysis.使用改良偏最小二乘判别分析对微卫星不稳定型结肠癌和子宫内膜癌中的癌症特异性基因进行优化
Medicine (Baltimore). 2024 Dec 27;103(52):e41134. doi: 10.1097/MD.0000000000041134.
6
Multi-omics analysis of core E3 ubiquitin ligase identifies prognostic biomarkers associated with immune infiltration and drug sensitivity in lung adenocarcinoma.核心E3泛素连接酶的多组学分析确定了与肺腺癌免疫浸润和药物敏感性相关的预后生物标志物。
J Cancer. 2025 Jan 20;16(4):1363-1378. doi: 10.7150/jca.104837. eCollection 2025.
7
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities.癌症、癌症免疫逃逸及潜在治疗机会中的泛素化酶
Cells. 2025 Jan 7;14(2):69. doi: 10.3390/cells14020069.
8
New insights into the role of ubiquitination in angiogenesis (Review).泛素化在血管生成中作用的新见解(综述)。
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5473. Epub 2024 Dec 20.
9
TAF15 inhibits p53 nucleus translocation and promotes HCC cell 5-FU resistance via post-transcriptional regulation of UBE2N.TAF15通过对UBE2N的转录后调控抑制p53核转位并促进肝癌细胞对5-氟尿嘧啶的耐药性。
J Physiol Biochem. 2024 Nov;80(4):919-933. doi: 10.1007/s13105-024-01053-8. Epub 2024 Oct 24.
10
The role of ubiquitin-conjugating enzyme in the process of spermatogenesis.泛素连接酶在精子发生过程中的作用。
Reprod Biol Endocrinol. 2024 Aug 28;22(1):110. doi: 10.1186/s12958-024-01282-y.
靶向CDC34 E2泛素结合酶用于肺癌治疗。
EBioMedicine. 2020 Apr;54:102718. doi: 10.1016/j.ebiom.2020.102718. Epub 2020 Apr 5.
4
Inhibiting ubiquitin conjugating enzyme E2 N by microRNA-590-3p reduced cell growth of cervical carcinoma.miR-590-3p 通过抑制泛素连接酶 E2 N 减少宫颈癌的细胞生长。
Kaohsiung J Med Sci. 2020 Jul;36(7):501-507. doi: 10.1002/kjm2.12204. Epub 2020 Mar 20.
5
Systematic identification of CDC34 that functions to stabilize EGFR and promote lung carcinogenesis.系统鉴定 CDC34,其功能是稳定 EGFR 并促进肺癌发生。
EBioMedicine. 2020 Mar;53:102689. doi: 10.1016/j.ebiom.2020.102689. Epub 2020 Feb 27.
6
High ubiquitin conjugating enzyme E2 T mRNA expression and its prognostic significance in lung adenocarcinoma: A study based on the TCGA database.高泛素结合酶E2T mRNA表达及其在肺腺癌中的预后意义:基于TCGA数据库的研究
Medicine (Baltimore). 2020 Jan;99(4):e18543. doi: 10.1097/MD.0000000000018543.
7
UBE2O promotes the proliferation, EMT and stemness properties of breast cancer cells through the UBE2O/AMPKα2/mTORC1-MYC positive feedback loop.UBE2O 通过 UBE2O/AMPKα2/mTORC1-MYC 正反馈环促进乳腺癌细胞的增殖、上皮间质转化和干性。
Cell Death Dis. 2020 Jan 6;11(1):10. doi: 10.1038/s41419-019-2194-9.
8
BRC-mediated RNAi targeting of USE1 inhibits tumor growth in vitro and in vivo.BRC介导的针对USE1的RNA干扰在体外和体内均抑制肿瘤生长。
Biomaterials. 2020 Feb;230:119630. doi: 10.1016/j.biomaterials.2019.119630. Epub 2019 Nov 22.
9
MicroRNA-1305 Inhibits the Stemness of LCSCs and Tumorigenesis by Repressing the UBE2T-Dependent Akt-Signaling Pathway.微小RNA-1305通过抑制依赖于泛素结合酶E2T的Akt信号通路来抑制肝癌干细胞的干性和肿瘤发生。
Mol Ther Nucleic Acids. 2019 Jun 7;16:721-732. doi: 10.1016/j.omtn.2019.04.013. Epub 2019 Apr 22.
10
A Comprehensive Bioinformatics Analysis of in Cancers.在癌症中 的综合生物信息学分析。
Int J Mol Sci. 2019 May 7;20(9):2228. doi: 10.3390/ijms20092228.